TREM-1 as a novel immunotherapeutic target to treat pancreatic ductal adenocarcinoma.

Saved in:
Bibliographic Details
Title: TREM-1 as a novel immunotherapeutic target to treat pancreatic ductal adenocarcinoma.
Authors: Gross L; Christine Kühne - Center for Allergy Research and Education, 7265 Davos, Switzerland.; Graduate School Cellular and Biomedical Sciences, University of Bern, 3012 Bern, Switzerland., Mutisheva I; Division of Experimental Pathology, Institute of Tissue Medicine and Pathology, University of Bern, 3008 Bern, Switzerland., Hillen H; Division of Experimental Pathology, Institute of Tissue Medicine and Pathology, University of Bern, 3008 Bern, Switzerland., Robatel S; Graduate School Cellular and Biomedical Sciences, University of Bern, 3012 Bern, Switzerland.; Division of Experimental Pathology, Institute of Tissue Medicine and Pathology, University of Bern, 3008 Bern, Switzerland., Wartenberg M; Division of Surgical Pathology, Institute of Tissue Medicine and Pathology, University of Bern, 3008 Bern, Switzerland., Ma F; Department of Cell and Developmental Biology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA., Bäriswyl L; Division of Experimental Pathology, Institute of Tissue Medicine and Pathology, University of Bern, 3008 Bern, Switzerland., Lee DJ; The Lundquist Institute for Biomedical Innovation, Torrance, CA 90502, USA.; Division of Dermatology, Department of Medicine, Harbor-UCLA Medical Center, Torrance, CA 90502, USA.; David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA., Modlin RL; David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA.; Division of Dermatology, School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA., Z'graggen K; Swiss Pancreas Clinic, 3013 Bern, Switzerland., Schenk M; Christine Kühne - Center for Allergy Research and Education, 7265 Davos, Switzerland.; Division of Experimental Pathology, Institute of Tissue Medicine and Pathology, University of Bern, 3008 Bern, Switzerland.
Source: Molecular therapy. Oncology [Mol Ther Oncol] 2025 Aug 14; Vol. 33 (3), pp. 201034. Date of Electronic Publication: 2025 Aug 14 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 9918752083706676 Publication Model: eCollection Cited Medium: Print ISSN: 2950-3299 (Print) Linking ISSN: 29503299 NLM ISO Abbreviation: Mol Ther Oncol Subsets: In Process
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40917508
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: TREM-1 as a novel immunotherapeutic target to treat pancreatic ductal adenocarcinoma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Gross+L%22">Gross L</searchLink>; Christine Kühne - Center for Allergy Research and Education, 7265 Davos, Switzerland.; Graduate School Cellular and Biomedical Sciences, University of Bern, 3012 Bern, Switzerland.<br /><searchLink fieldCode="AU" term="%22Mutisheva+I%22">Mutisheva I</searchLink>; Division of Experimental Pathology, Institute of Tissue Medicine and Pathology, University of Bern, 3008 Bern, Switzerland.<br /><searchLink fieldCode="AU" term="%22Hillen+H%22">Hillen H</searchLink>; Division of Experimental Pathology, Institute of Tissue Medicine and Pathology, University of Bern, 3008 Bern, Switzerland.<br /><searchLink fieldCode="AU" term="%22Robatel+S%22">Robatel S</searchLink>; Graduate School Cellular and Biomedical Sciences, University of Bern, 3012 Bern, Switzerland.; Division of Experimental Pathology, Institute of Tissue Medicine and Pathology, University of Bern, 3008 Bern, Switzerland.<br /><searchLink fieldCode="AU" term="%22Wartenberg+M%22">Wartenberg M</searchLink>; Division of Surgical Pathology, Institute of Tissue Medicine and Pathology, University of Bern, 3008 Bern, Switzerland.<br /><searchLink fieldCode="AU" term="%22Ma+F%22">Ma F</searchLink>; Department of Cell and Developmental Biology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.<br /><searchLink fieldCode="AU" term="%22Bäriswyl+L%22">Bäriswyl L</searchLink>; Division of Experimental Pathology, Institute of Tissue Medicine and Pathology, University of Bern, 3008 Bern, Switzerland.<br /><searchLink fieldCode="AU" term="%22Lee+DJ%22">Lee DJ</searchLink>; The Lundquist Institute for Biomedical Innovation, Torrance, CA 90502, USA.; Division of Dermatology, Department of Medicine, Harbor-UCLA Medical Center, Torrance, CA 90502, USA.; David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA.<br /><searchLink fieldCode="AU" term="%22Modlin+RL%22">Modlin RL</searchLink>; David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA.; Division of Dermatology, School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA.<br /><searchLink fieldCode="AU" term="%22Z'graggen+K%22">Z'graggen K</searchLink>; Swiss Pancreas Clinic, 3013 Bern, Switzerland.<br /><searchLink fieldCode="AU" term="%22Schenk+M%22">Schenk M</searchLink>; Christine Kühne - Center for Allergy Research and Education, 7265 Davos, Switzerland.; Division of Experimental Pathology, Institute of Tissue Medicine and Pathology, University of Bern, 3008 Bern, Switzerland.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229918752083706676%22">Molecular therapy. Oncology</searchLink> [Mol Ther Oncol] 2025 Aug 14; Vol. 33 (3), pp. 201034. <i>Date of Electronic Publication: </i>2025 Aug 14 (<i>Print Publication: </i>2025).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Inc%22">Elsevier Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9918752083706676 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2950-3299 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2229503299%22">29503299 </searchLink><i>NLM ISO Abbreviation: </i>Mol Ther Oncol <i>Subsets: </i>In Process
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40917508
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.omton.2025.201034
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 201034
    Titles:
      – TitleFull: TREM-1 as a novel immunotherapeutic target to treat pancreatic ductal adenocarcinoma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Gross L
      – PersonEntity:
          Name:
            NameFull: Mutisheva I
      – PersonEntity:
          Name:
            NameFull: Hillen H
      – PersonEntity:
          Name:
            NameFull: Robatel S
      – PersonEntity:
          Name:
            NameFull: Wartenberg M
      – PersonEntity:
          Name:
            NameFull: Ma F
      – PersonEntity:
          Name:
            NameFull: Bäriswyl L
      – PersonEntity:
          Name:
            NameFull: Lee DJ
      – PersonEntity:
          Name:
            NameFull: Modlin RL
      – PersonEntity:
          Name:
            NameFull: Z'graggen K
      – PersonEntity:
          Name:
            NameFull: Schenk M
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 14
              M: 08
              Text: 2025 Aug 14
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 2950-3299
          Numbering:
            – Type: volume
              Value: 33
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Molecular therapy. Oncology
              Type: main
ResultId 1